Clinical Trial Update: Impact on Atrial Remodeling of Dapaglifozin in Patients With Heart Failure . [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the impact of dapagliflozin on atrial remodeling in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia | Conditions: Heart Failure | Phase 3 | Status: COMPLETED